Article Details
Retrieved on: 2022-01-19 16:01:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Discontinuations include ABBV-428 and Astrazeneca's MEDI5083, while Roche recently canned selicrelumab in favour of RG6189, a bispecific that ...
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here